Weekly paclitaxel treatment of patients with progressive platinum resistant epithelial ovarian cancer.

被引：0
|
作者：
Le, T [1 ]
Baines, KA [1 ]
Rambout, L [1 ]
Rezaifer, P [1 ]
Al Hayki, M [1 ]
Hopkins, L [1 ]
Fung, MFK [1 ]
机构：
[1] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：488S / 488S
页数：1
相关论文
共 50 条
  • [1] Phase II study of weekly paclitaxel carboplatin in the treatment of progressive ovarian cancer.
    Van der Burg, ME
    Vergote, I
    Burger, CW
    van der Gaast, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 463S - 463S
  • [2] A study of weekly Taxol® in patients with recurrent platinum resistant ovarian cancer.
    Kaern, J
    Tropé, C
    Baekelandt, M
    Kristensen, GB
    Gundersen, G
    ANNALS OF ONCOLOGY, 2000, 11 : 85 - 85
  • [3] A phase II study of weekly paclitaxel in platinum and paclitaxel-resistant ovarian cancer patients
    Kaern, J
    Baekelandt, M
    Tropé, CH
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (05) : 383 - 389
  • [4] WEEKLY PACLITAXEL-CARBOPLATINUM IS EFFECTIVE IN PLATINUM-RESISTANT OVARIAN CANCER PATIENTS AFTER PREVIOUS WEEKLY PACLITAXEL
    Concin, N.
    Salihi, R.
    Lage, T.
    Van Nieuwenhuysen, E.
    Neven, P.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 664 - 664
  • [5] A phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.
    Swensen, R. E.
    Childs, J.
    Higgins, D.
    Gooley, T.
    Goff, B. A.
    Fintak, P. A.
    Buening, B.
    Disis, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer
    Le, T.
    Hopkins, L.
    Baines, K. A.
    Rambout, L.
    Al Hayki, M.
    Fung, M. Kee Fung
    GYNECOLOGIC ONCOLOGY, 2006, 102 (01) : 49 - 53
  • [7] Vinorelbine for the treatment of recurrent progressive platinum-resistant epithelial ovarian cancer
    Berry, E.
    Hoekstra, A. V.
    Singh, D. K.
    Buttin, B. M.
    Schink, J. C.
    Lurain, J. R.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 365 - 365
  • [8] Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer
    Oza, Amit
    Kaye, Stanley
    Van Tornout, Jan
    Sessa, Cristiana
    Gore, Martin
    Naumann, R. Wendel
    Hirte, Hal
    Colombo, Nicoletta
    Chen, Jihong
    Gorla, Seema
    Poondru, Srinivasu
    Singh, Margaret
    Steinberg, Joyce
    Yuen, Geoff
    Banerjee, Susana
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 275 - 282
  • [9] Bevacizumab exposure and tumor response in patients with platinum resistant epithelial ovarian cancer.
    Michels, Judith
    Hamimed, Mourad
    Menu, Yves
    Balleyguier, Corinne
    Ghiringhelli, Francois
    Frenel, Jean-Sebastien
    Genestie, Catherine
    You, Benoit
    Floquet, Anne
    Eberst, Lauriane
    Paci, Angelo
    Bahleda, Rastilav
    Pautier, Patricia
    Colomba, Emeline
    Pommeret, Fanny
    Leary, Alexandra
    Marabelle, Aurelien
    Bardet, Aurelie
    Brard, Caroline
    Ciccolini, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] EXPERIENCE OF WEEKLY DOSE DENSE CARBOPLATIN AND PACLITAXEL IN PLATINUM RESISTANT OVARIAN CANCER
    Roxburgh, P.
    Sharma, R.
    Brooks, A.
    Reed, N.
    Gabra, H.
    Glasspool, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 212 - 212
12345